Freenome, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Freenome, Inc.'s yearly results, compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
—Data incomplete
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-10.9×Operating cash was negative last year, while some debt falls due within a year.
Higher than 53% of Healthcare companies in United States.
Cash Cushion Ratio
−7%Debt, after subtracting cash, equals 7% of its market value (net debt).
Lower than 76% of Healthcare companies in United States.
Tangible Assets Ratio
97%Of every $100 the company owns, $97 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 81% of Healthcare companies in United States.
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (11)
Freenome, Inc. made a loss over the last year. Freenome, Inc. owes $3.49 for every $1 it owns. Freenome, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossFreenome, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
-1.11Freenome, Inc.'s book value is negative (it owes more than it owns), so P/B is not meaningful.
Market cap
$1.4 BThe total market value of all of Freenome, Inc.'s shares at today's price (share price × number of shares), larger than 68% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
NegativeFreenome, Inc.'s net worth is negative ($1.3 B below zero, balance sheet 31 Dec 2025): it owes more than it owns, so book value per share and P/B are not meaningful.
Owes vs Owns
3.49×Freenome, Inc. owes $3.49 for every $1 it owns, so it owes more than it owns, higher than 98% of Healthcare companies in United States.
Dividend yield
NoneFreenome, Inc. does not currently pay a dividend.
Revenue growth
+955%Revenue rose 955% in the year to Dec 2025.
Profit growth
LossFreenome, Inc. made a loss in each of the last two years.
Profit margin
-721.3%Freenome, Inc. lost $721 for every $100 of revenue.
Interest cover
Not coveredFreenome, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net debtFreenome, Inc. had $95 M more debt than cash (net debt) at Dec 2025.
Questions
How much does Freenome, Inc. owe compared with what it owns?
Freenome, Inc. owes $3.49 for every $1 it owns, so it owes more than it owns, higher than 98% of Healthcare companies in United States.
Does Freenome, Inc. pay a dividend?
No. Freenome, Inc. does not currently pay a dividend.
Is Freenome, Inc.'s revenue growing?
Revenue rose 955% in the year to Dec 2025.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.